Hitoshi Sasaki
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Linked color imaging improves visibility of reflux esophagitis.
Journal: BMC gastroenterology
Published: June 06, 2020
Current status of first- and second-line Helicobacter pylori eradication therapy in the metropolitan area: a multicenter study with a large number of patients.
Journal: Therapeutic advances in gastroenterology
Published: March 18, 2019
Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users.
Journal: Biomedical reports
Published: December 12, 2018
A Systematic Review of the Effectiveness of Antianxiety and Antidepressive Agents for Functional Dyspepsia.
Journal: Internal medicine (Tokyo, Japan)
Published: October 13, 2017
Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?
Journal: Therapeutics and clinical risk management
Published: April 03, 2015
Pretreatment prediction of symptom response to proton pump inhibitor therapy.
Journal: Journal of gastroenterology and hepatology
Published: April 02, 2015
Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group).
Journal: Journal of gastroenterology and hepatology
Published: December 19, 2014
Upper gastrointestinal mucosal injury and symptoms in elderly low-dose aspirin users.
Journal: Gastroenterology research and practice
Published: November 17, 2014
A Randomized Prospective Study of Bowel Preparation for Colonoscopy with Low-Dose Sodium Phosphate Tablets versus Polyethylene Glycol Electrolyte Solution.
Journal: Gastroenterology research and practice
Published: June 26, 2014
The Relationship between H. pylori Infection and Osteoporosis in Japan.
Journal: Gastroenterology research and practice
Published: April 30, 2014
A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan.
Journal: Scandinavian journal of gastroenterology
Published: January 22, 2014
Last Updated: 09/26/2026